Back
ESC Premium Access

State of the Art - Optimizing the prevention of venous thromboembolism

Session: Progress in anticoagulation for venous thromboembolism
Topic: Treatment
Speaker: Professor A. Spyropoulos (New York, US)
Event: ESC Congress 2018

Congress Presentation

About the speaker

Professor Alex Spyropoulos

Northwell Health, New York (United States of America)
4 presentations
0 follower

3 more presentations in this session

Asian patients versus non-Asian patients in the efficacy and safety of direct oral anticoagulants relative to vitamin K antagonist for venous thromboembolism: a systemic review and meta-analysis

Speaker: Doctor Y. Yamashita (Kyoto, JP)

Access
Abstract
Slides
Video
Thumbnail

Predictive value of VTE-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with venous thromboembolism: results of the XALIA study

Speaker: Doctor E. Klok (Leiden, NL)

Access
Abstract
Thumbnail

Betrixaban versus enoxaparin for venous thromboembolism prophylaxis in critically ill patients: findings from the APEX trial

Speaker: Doctor A. Kalayci Karabay (Boston, US)

Access
Abstract
Slides
Video
Thumbnail

Access the full session

Progress in anticoagulation for venous thromboembolism

Speakers: Professor A. Spyropoulos, Doctor Y. Yamashita, Doctor E. Klok, Doctor A. Kalayci Karabay
Access
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb